DOCSLIB.ORG

5-Country RAR Report Lenka Vavrincikova, Hana Fidesova, Barbara Janikova & Jean-Paul Grund

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
5-Country RAR Report Lenka Vavrincikova, Hana Fidesova, Barbara Janikova & Jean-Paul Grund New Psychoactive Substances among People Who Use Drugs Heavily. Towards Effective and Comprehensive Health Responses in Europe. 5-country RAR report Lenka Vavrincikova, Hana Fidesova, Barbara Janikova & Jean-Paul Grund New Psychoactive Substances among People Who Use Drugs Heavily. Towards Effective and Comprehensive Health Responses in Europe. Department of Addictology First Faculty of Medicine Charles University in Prague General University Hospital in Prague Czech Republic February 2016 JUST/2013/DPIP 4000004774 (1/3/2014 to 28/2/2016) Disclaimer "This publication has been produced with the financial support of the Drug Prevention and Information Programme of the European Union. The contents of this publication are the sole responsibility of the implementing partners: Agência Piaget Para o Desenvolvimento – APDES (Portugal), Charles University in Prague – CUNI (Czech Republic), De Regenboog Groep (RG) (The Netherlands), Carusel Association (Romania), Programs of Development, Social Support and Medical Cooperation – PRAKSIS (Greece), SANANIM (Czech Republic), and MONAR – Association, Outpatients Clinic in Krakow (Poland), and can in no way be taken to reflect the views of the European Commission." New Psychoactive Substances among People Who Use Drugs Heavily. Towards Effective and Comprehensive Health Responses in Europe. 5-country RAR report Lenka Vavrincikova, Hana Fidesova, Barbara Janikova & Jean-Paul Grund Acknowledgements Financial support for this study was provided by the Drug Prevention and Information Program of the European Union under the EU-DPIP project: “New Psychoactive Substances among PUDH - Towards Effective and Comprehensive Health Responses in Europe” JUST/2013/DPIP/AG/4774. Institutional support was provided by Charles University in Prague No. PRVOUK-P03/LF1/9. We would like to thank both our core partners Agência Piaget Para o Desenvolvimento in Porto, Portugal and De Regenboog Groep in Amsterdam, The Netherlands and our implementing partners, Sananim, Prague, Czech Republic; Praksis, Athens, Greece; Monar, Krakov, Poland; APDES & Vila Nova de Gaia, Portugal; and Carusel, Bucharest, Romania, the local RAR teams, focus group participants and external (peer) experts for their contributions and dedication to the project. It was a pleasure working with you all. 1 Contents 1. Introduction .............................................................................................................................................. 4 1.1 Aims of the RAR study ....................................................................................................................... 4 1.2 Key RAR questions ............................................................................................................................. 4 1.3 Target countries and partner organizations ...................................................................................... 5 1.4 Key concepts of the project ............................................................................................................... 5 1.4.1 Operationalizing the project definition of NPS - New to Whom? ............................................................ 5 1.4.2 Defining Target Groups – People who Use Drugs Heavily (PUDH) ........................................................... 6 2. Methodology ............................................................................................................................................. 7 2.1 The Desk review ................................................................................................................................ 7 2.2 Assessment of NPS availability in offline and online drug markets ................................................... 7 2.3 The Focus Group Methodology ......................................................................................................... 8 2.4 RAR analysis ...................................................................................................................................... 9 2.5 Study Limitations ............................................................................................................................. 10 2.6 Report structure .............................................................................................................................. 10 3. Findings ................................................................................................................................................... 11 3.1 Five-country desk review of the national NPS situation ................................................................. 11 3.1.1 The Czech Republic ................................................................................................................................ 11 3.1.2 Greece .................................................................................................................................................... 14 3.1.3 Poland .................................................................................................................................................... 16 3.1.4 Portugal .................................................................................................................................................. 18 3.1.5 Romania ................................................................................................................................................. 20 3.2 Assessment of NPS availability in offline and online drug markets in the participating countries . 22 3.2.1 Czech Republic ......................................................................................................................................... 1 3.2.2 Greece ...................................................................................................................................................... 2 3.2.3 Poland ...................................................................................................................................................... 3 3.2.4 Portugal .................................................................................................................................................... 5 3.2.5 Romania ................................................................................................................................................... 6 3.2.6 Discussion ................................................................................................................................................. 7 3.3 NPS stakeholder focus groups ........................................................................................................... 8 3.3.1 Czech Republic ......................................................................................................................................... 8 3.3.2 Greece ...................................................................................................................................................... 9 3.3.3 Poland ...................................................................................................................................................... 9 3.3.4 Portugal .................................................................................................................................................. 10 3.3.5 Romania ................................................................................................................................................. 11 3.3.6 Discussion ............................................................................................................................................... 11 3.3.7 Focus Group Conclusion ......................................................................................................................... 17 4. Discussion: similarities and differences between the five countries ...................................................... 18 4.1.1 Availability of NPS in the participating countries ................................................................................... 18 4.1.2 Extent and nature of NPS use among PUDH .......................................................................................... 19 2 4.1.3 Factors in choosing NPS ......................................................................................................................... 20 4.1.4 Positive and negative effects reported; health consequences .............................................................. 21 4.1.5 Interventions and policies targeting NPS ............................................................................................... 23 4.1.6 Pointers for intervention and policy development ................................................................................ 23 5. Conclusions ............................................................................................................................................. 24 6. Country Summaries ................................................................................................................................. 26 The Czech Republic .................................................................................................................................................. 26 Greece 27 Poland 27 Portugal 28 Romania 29 7. References ............................................................................................................................................... 30 8. Annexes: data reporting and grid analysis forms ...................................................................................
Load more

Recommended publications
  • Ormond Beach Daytona Beach Holly Hill Your Own
    GROW INSIDE ORMOND BEACH DAYTONA BEACH HOLLY HILL YOUR OWN In Garden Nook: Orchids not that hard Page A13 Vol. 6, No. 31 Your Local News and Information Source • www.HometownNewsOL.com Friday, Aug. 26, 2011 Community New state laws mean less You can earn money from home talking about what you already know! If you feel like you Notes are an expert on anything, sign up start earning money as a FREE oversight for local development Broadcaster!and Dance clinic planned • STREAM & SELL YOUR VIDEOS • STREAM AND SELL YOUR LIVE EVENTS By John Bozzo Mr. Goss said this will mean less is what local govern- • VIDEOS ON DEMAND ENCORE Baton & Dance For Hometown News paperwork but more responsibility ments use to regu- studio in Holly Hill will hold Also Offering Videos on Demand for local officials, who are still sort- late land use within Sell your event or educational videos online. a free show and clinic from ORMOND BEACH — With slides ing out what the new law means their cities. They 9:30 a.m. to noon, Saturday, projected on a screen in a small and how decisions in one commu- are used to plan for Aug. 27. No experience is room, the City Commission recent- nity will impact a neighboring the needs of the SIGN UP FOR FREE! necessary. ly studied what responsibilities a community. communities and WWW.HDBroadcasters.COM For more information new state law on growth and urban While many believe the relax- to protect natural about this free clinic, call planning will place in their hands.
    [Show full text]
  • Download Book Sacred Journeys As
    Sa cred Jour neys: ©2015, 2016, 2017 Artscience Im ages: authors and friends, com pany and press pic- tures, PhotoDisc, Corel, Wikipedia, Mindlift Beeldbankiers. Dis tri bu tion: Boekencoöperatie Nederland u.a. email: [email protected] www.boekcoop.nl www.boekenroute.nl (webshop) All rights re served, in clud ing dig i tal re dis tri bu tion and ebook First editiion: De cem ber 2015, Sec ond, ap pended edition April 2016 Third edition Jan. 2017 ISBN 9789492079091 pub lisher: Onderstroomboven Collectief im print: Artscience. Pa perback price € 6,95 Con tents 1 Pre fa ce 7 2 Tripping: the process 10 Journey to the dream 10 The pre pa ra ti on 11 Pha ses, gig gling 13 Iso la ti on, li mi na li ty, the dark 14 Peak 19 Sit ters: de sig na ted hel pers 22 The mys ti cal, re gres si on 26 Rebirth and de ath 27 The end of the trip: co ming down 28 Over sti mu la ti on 29 The af ter-ef fects 30 3 Set and Set ting 32 Agen da 33 Pla ce 34 With whom, with what? 34 Bon ding and trans fe ren ce 35 Dif fe rent ways of using 36 4 Pur po se 37 Dee per goals 38 Over co ming fear 40 To le ran ce 41 5 Ri tu als and Group ses sions 42 He a ling jour neys, mys ti cal in sights 44 Me di cal use 45 Re pe ti ti on, loops 46 Stages of a ritu al 49 Ri tes of pas sa ge: ini ti a ti on 50 Contact – alignment - group mind 52 Struc tu re amidst cha os 54 To copy an existing ritu al or to crea te somet hing new 54 6 Sanc tu a ry, safe spa ce 57 Sa fe ty first 57 Sa cred spa ce, tem po ra ry au to no mous zone 58 Hol ding spa ce and cir cle in te gri ty 61 7 His to ry
    [Show full text]
  • Nove Psihoaktivne Tvari
    TRENUTNO AKTIVNI SMART SHOPOVI U RH SINTETSKI KANABINOIDI TRIPTAMINI TOBACOO I VIDEOTEKA - ČAKOVEC Tvari koji oponašaju učinke kanabisa. Tvari koje izazivaju halucinogeno djelovanje. ■■Ulica kralja Tomislava 4 Vežu se na kanabinoidne receptore CB1 i CB2. SEKS SHOP I SMART SHOP - KOPRIVNICA ■■Ivana Generalić 3 HEAD SHOP SHOP - OSIJEK ■■Strossmayerova 39 SMART SHOP ART-MUSIK - PULA z primjeri kemijskih naziva: 5-MeO-DMT, 5-MeO-AMT, DPT ■■Zadarska 3 ■ IGROW SHOP - RIJEKA ■ izazivaju halucinogeno djelovanje; ■■Blaža Polića 5 najčešće se konzumiraju pušenjem, oralno, ušmrkavanjem, inhalacijom, injektiranjem SMART SHOP” - SLAVONSKI BROD ■■mijenjaju doživljaj realnosti, uzrokuju strah, ■■Starčevića 23 tjeskobu, povećanje srčanog pulsa IGROW SHOP - SPLIT ■■Mihovilova širina 19 z primjeri kemijskih naziva: JWH-018, NOVE JWH-250, JWH-122, AM-2201, RCS-04, SMART SHOP - ŠIBENIK DRUGI ■■Zagrebačka 9 UR-144, 5F UR-144, 5Cl UR-144 PSIHOAKTIVNE SNAIL SMART SHOP - ZADAR Tvari koje ne pripadaju niti jednoj od ■■mješavina bilja koja se reklamira kao “egzotični ■■Stomorica 2 navedenih skupina. Pojavljuju se u obliku mirisi” ili osvježivači prostora uz čestu TVARI SMART SHOP - ZAGREB napomenu kako nisu za konzumaciju tableta, praha, biljnih pripravaka te ■ ■ Maradona smart shop Tkalčićeva 12 ■■sadrže sintetske kanabinoide pa se uzrokuju različite psihoaktivne učinke. ■Grow shopzg Ilica 93 ■ pušenjem postižu učinci slični kanabisu ■■King size head shop Petrinjska 4 ■ ■■Smart shop Apoteka Selska 215 ■ imaju psihoaktivni učinak sličan učinku ■■Nail grow shop
    [Show full text]
  • Psychedelic Resource List (PRL) Was Born in 1994 As a Subscription-Based Newsletter
    A Note from the Author… The Psychedelic Resource List (PRL) was born in 1994 as a subscription-based newsletter. In 1996, everything that had previously been published, along with a bounty of new material, was updated and compiled into a book. From 1996 until 2004, several new editions of the book were produced. With each new version, a decrease in font size correlated to an increase in information. The task of revising the book grew continually larger. Two attempts to create an updated fifth edition both fizzled out. I finally accepted that keeping on top of all of the new books, businesses, and organizations, had become a more formidable challenge than I wished to take on. In any case, these days folks can find much of what they are looking for by simply using an Internet search engine. Even though much of the PRL is now extremely dated, it occurred to me that there are two reasons why making it available on the web might be of value. First, despite the fact that a good deal of the book’s content describes things that are no longer extant, certainly some of the content relates to writings that are still available and businesses or organizations that are still in operation. The opinions expressed regarding such literature and groups may remain helpful for those who are attempting to navigate the field for solid resources, or who need some guidance regarding what’s best to avoid. Second, the book acts as a snapshot of underground culture at a particular point in history. As such, it may be found to be an enjoyable glimpse of the psychedelic scene during the late 1990s and early 2000s.
    [Show full text]
  • List of Psychoactive Drug Spirits for MD A-Methylfentanyl, Abilify
    List of Psychoactive Drug Spirits for MD A-Methylfentanyl, Abilify, abnormal basal ganglia function, abuse of medicines, Aceperone, Acepromazine, Aceprometazine, Acetildenafil, Aceto phenazine, Acetoxy Dipt, Acetyl morphone, Acetyl propionyl morphine, Acetyl psilocin, Activation syndrome, acute anxiety, acute hypertension, acute panic attacks, Adderall, Addictions to drugs, Addictions to medicines, Addictions to substances, Adrenorphin, Adverse effects of psychoactive drugs, adverse reactions to medicines, aggression, aggressive, aggressiveness, agitated depression, Agitation and restlessness, Aildenafil, Akuammine, alcohol abuse, alcohol addiction, alcohol withdrawl, alcohol-related brain damage, alcohol- related liver damage, alcohol mix with medicines for adverse reaction, Alcoholism, Alfetamine, Alimemazine, Alizapride, Alkyl nitrites, allergic breathing reactions to meds, choking to anaphallectic shock, & death; allergic skin reactions to meds, rash, itchyness, hives, welts, etc, Alletorphine, Almorexant, Alnespirone, Alpha Ethyltryptamine, Alpha Neoendorphin, alterations in brain hormones, alterations in mental status, altered consciousness, altered mind, Altoqualine, Alvimopan, Ambien, Amidephrine, Amidorphin, Amiflamine, Amisulpride, Amphetamines, Amyl nitrite, Anafranil, Analeptic, Anastrozole, Anazocine, Anilopam, Antabuse, anti anxiety meds, anti dopaminergic activity, anti seizure meds, Anti convulsants, Anti depressants, Anti emetics, Anti histamines, anti manic meds, anti parkinsonics, Anti psychotics, Anxiety disorders,
    [Show full text]
  • View Numinus' Briefing Note to Health Canada Here
    November 20, 2020 Patty Hajdu Honourable Minister of Health Health Canada Email: [email protected] Dear Minister Hajdu, On behalf of the Numinus Wellness Clinical Advisory Board*, please find enclosed a briefing note and appendices making recommendations for the revision of Health Canada’s Special Access Programme. We would appreciate the opportunity to have a follow up call with relevant Health Canada staff to review these recommendations if this would be of assistance. Sincerely, ____________________________ ____________________________ Evan Wood, MD, PhD, FRCPC Devon Christie, MD, CCFP, RTC Chief Medical Officer Medical Director *Gabor Maté, M.D.,C.M, Author & Retired Physician, Pam Kryskow, M.D., CCFP, Physician & Clinical Instructor, UBC, Zach Walsh, PhD, Professor, Psychology, UBC, Kate Browning RN, Administrator & Instructor, Holistic Health, Langara College, Dr. Jason Marr, BScH, COC, ND, Founder & Director of Evoke Integrative Medicine Ltd. cc: Pierre Sabourin, Assistant Deputy Minister Health Products and Food Branch, Health Canada Email: [email protected] Eric Costen, Associate Assistant Deputy Minister Controlled Substances and Cannabis Branch, Health Canada Email: [email protected] numinus.ca [email protected] TITLE: Revising Health Canada’s Special Access Program to Allow Pre-Approval Access to MDMA and Psilocybin PREPARED FOR: Patty Hajdu, Honourable Minister of Health DATE: November 20, 2020 ISSUE: There is a large and growing burden of mental illness affecting Canadians. In some cases, this is severe and can be life threatening for a range of reasons (e.g. opioid overdose, suicide). Existing treatments for severe mental illness are often ineffective and associated with unwanted side effects meaning new treatment modalities are urgently needed.
    [Show full text]
  • Synthetic Drug Trafficking in Amsterdam I
    Section I Synthetic Drug Trafficking in Amsterdam I. Amsterdam Introduction This section contains the results of a study on synthetic drug trafficking in Amsterdam, with special attention given to its mid-level segment. Research was done as part of the project “Synthetic Drug Trafficking in Three European Cities: Major Trends and the Involvement of Organised Crime” promoted by Gruppo Abele (Italy) in cooperation with the Transnational Institute (TNI – The Netherlands) and the Institute for Studies on Conflicts and Humanitarian Actions (IECAH – Spain), with the support of the United Nations Interregional Crime and Justice Research Institute (UNICRI) based in Italy. The project was co-financed by the European Commission (reference number JAI/B5831/2001/004), begun at the end of 2001 and continued throughout 2002 in three European cities: Amsterdam, Barcelona and Turin. The Amsterdam team was made up of Tom Blickman (coordinator), Dirk J. Korf, Dina Siegel and Damián Zaitch. Terminology Interviews with mid-level dealers made up the core of this research. But what is meant by “mid-level dealer”? Mid-level can be anything between dealing wholesale (first-hand) to retail (final transaction). However, this research showed not all deal- ers limit themselves to one level. Consequently, dealers can be difficult to define though not levels. We categorised the levels as follows: WHOLESALE: transactions at “first hand” distribution (the first buyer from the pro- ducer) which can involve quantities of between 10,000 and 50,000 to over a million pills depending on the customers; MID-LEVEL: the level of intermediaries who buy from wholesalers and distribute to retailers, involving amounts of between 1,000 and 50,000 pills depending once again on the customers; RETAIL: direct consumer sales, supplied by intermediates, starting at about 1,000 pills.
    [Show full text]
  • New Psychoactive Substances. a Challenge to Public Health
    portada_AF_ingles.pdf 1 24/07/14 10:57 O H N CH3 CH3 NEW PSYCHOACTIVE OH H SUBSTANCES. H OH O A CHALLENGE TO PUBLIC HEALTH The Spanish Early Warning System C O OH H M H OH Y CM O H MY N CH3 CY CH3 CMY K OH H H OH O O OH H Financed by: H OH SECRETARÍA DE ESTADO SECRETARÍA DE ESTADO DE SERVICIOS SOCIALES DE SERVICIOS SOCIALES E IGUALDAD E IGUALDAD MINISTERIO MINISTERIO DE SANIDAD, SERVICIOS SOCIALES DE SANIDAD, SERVICIOS SOCIALES E IGUALDAD DELEGACIÓN DEL GOBIERNO E IGUALDAD DELEGACIÓN DEL GOBIERNO PARA EL PLAN NACIONAL SOBRE DROGAS PARA EL PLAN NACIONAL SOBRE DROGAS NEW PSYCHOACTIVE SUBSTANCES. A CHALLENGE TO PUBLIC HEALTH The Spanish Early Warning System Authors: Julia González Alonso Noelia Llorens Aleixandre We would like to thank the Spanish Government Office for the National Drug Plan, and in particular, Mr. Francisco de Asís Babín (Government Delegate), Mr. José Oñorbe (Deputy Director), Ms. Rosario Sendino and Ms. Elena Álvarez, for their collaboration and support. Translation by: Álvaro Ruiz del Real and Marta Jiménez Bermejo Layout and printing: SERVICIOS ADI EDITORIALES www.auladoc.com Legal deposit: M-21193-2014 ISBN: 978-84-940849-5-9 NEW PSYCHOACTIVE SUBSTANCES A CHALLENGE TO PUBLIC HEALTH Presentation The Association of Experts for the Development of Social Programs (Asociación de Técnicos para el Desarrollo de Programas Sociales, or ADES, Spanish acronym), in collaboration with the Spanish Government Office for the National Drug Plan (DGPNSD, Spanish acronym) has developed training and refresher programs on drug addiction
    [Show full text]
  • 20 Years Mushroom Magazine Mat Mushroom | a Lot of Artist Interviews Festival A-Z | Festival Packing List | Festival Map
    #183 Summer 2014 www.mushroom-magazine.com 20 years mushroom magazine Mat Mushroom | A lot of Artist Interviews Festival A-Z | Festival Packing List | Festival Map psychedelic trance music & culture psychedelic trance H.R.Giger | Alexander Shulgin | Police Control Special INTRO 3 20 YEARS Nun ist es doch tatsächlich MUSHROOM 20 Jahre her, seitdem ich diese fixe Idee hatte zu den MAGAZINE ! damalig von mir veranstalteten Now it‘s been in fact 20 years “mushroom club” Parties ein kleines kopiertes Faltblatt mit since I photocopied and then weiterführenden Szeneinfos distributed a small leaflet with zu verteilen, welches ich “your further info about the scene persoal mushroom” nannte. In during my parties, an idée fixe den letzten 20 Jahre hat sich really which I called “your per- dann die gesamte Musikwelt sonal mushroom”. In these last neu erfunden: Aus Vinyls 20 years the entire music world The mushroom birthday cake was wurden CDs, aus CDs wurden made by BAKING BAD GERMANY. frei kopierbare Musikdaten has re-invented itself: vinyls became im Internet. Doch auch wenn CDs, CDs became free-downloadable Thanks to Lucy Mushroom and Gina Glückspilz dadurch damals viele Labels music data on the Internet. Even starben, wurde die Musik though many a label has died because of this then, music got to be gleichsam weltweit verfügbar available world-wide and our scene became a world-wide movement. und machte aus unserer Szene eine weltweite Bewegung. We have been pursuing this international approach for quite some time Diesen internationalen Ansatz now. By relaunching our website and simultaneously publishing the verfolgen wir nun schon sehr birthday-edition of the psychedelic travel guide Trancers Guide To The lange.
    [Show full text]
  • ADVERTIMENT. Lʼaccés Als Continguts Dʼaquesta Tesi Queda
    ADVERTIMENT. Lʼaccés als continguts dʼaquesta tesi queda condicionat a lʼacceptació de les condicions dʼús establertes per la següent llicència Creative Commons: http://cat.creativecommons.org/?page_id=184 ADVERTENCIA. El acceso a los contenidos de esta tesis queda condicionado a la aceptación de las condiciones de uso establecidas por la siguiente licencia Creative Commons: http://es.creativecommons.org/blog/licencias/ WARNING. The access to the contents of this doctoral thesis it is limited to the acceptance of the use conditions set by the following Creative Commons license: https://creativecommons.org/licenses/?lang=en DEPARTAMENTO DE FARMACOLOGÍA, TERAPÉUTICA Y TOXICOLOGÍA PROGRAMA DE DOCTORADO EN FARMACOLOGÍA TESIS DOCTORAL Patrones de consumo de nuevas drogas de síntesis. Farmacología de la 2C-B. Memoria presentada por la licenciada en Psicología Débora González Muñoz-Caballero para optar al título de doctora por la Universidad Autónoma de Barcelona en el programa de doctorado de Farmacología, bajo la dirección del doctor Magí Farré Albadalejo, profesor de farmacología del Departamento de Farmacología, Terapéutica y Toxicología de la UAB, y jefe de servicio en el Departamento de Farmacología Clínica en el Hospital Universitari Germans Trias i Pujol. Débora González Muñoz-Caballero Magí Farré Albaladejo Firma:!!!!!!!!!!! Firma: Magí Farré Albaladejo, Catedràtic de Farmacologia del Departament de Farmacologia, de Terapèutica i de Toxicologia de la Universitat Autònoma de Barcelona, FA CONSTAR: Que la memòria presentada per Debora González Muñoz -Caballero amb títol “Patrones de consumo de nuevas drogas de síntesis. Farmacología de la 2C-B”, ha estat realitzada sota la seva direcció. La memòria reuneix les condicions per ser presentada per optar al grau de Doctor.
    [Show full text]
  • One Hundred to One (Second Edition)
    ONE HUNDRED TO ONE (SECOND EDITION) SIMON RACKHAM COPYRIGHT © SIMON RACKHAM 2000 A BIG THING IS BETTER UNDISPUTEDLY SO NO EVERY THING IS DISPUTABLE YES THAT MUCH I GIVE ME SO SOON INTRODUCED NEVER TOO EARLY IN MY BOOK NOT THAT THIS IS BUT WHO IS IT OR WHO ARE THOSE WHO MAKE UP THE RULES THE RULERS OR THEM THEM WHO LOVE TO BE RULED NOT THAT THERES A DIFFERENCE ANY WAY IS OK BY ME OK VERY STRANGE ANY WAY ANYHOW ONE AND ONE STILL EQUALS TWO WHATEVER YOU OR THOSE HAVE TO SAY OF IT DONT BE SO SURE SONNY JIM FACTION IS WEIRDER THAN EVEN THEY CAN IMAGINE OR THINK OF WHO EVER THEY BE THEM ALL THE REST OF YOUS LOT PUT TOGETHER YES THAT INCLUDES YOU TOO AND YOUR TYPE IVE SEEN EM ALL SPARKLY BIG BIRD EYES AND ALL THE REST TO BOOT DONT THINK I DIDNT NOTICE CAUSE I DID SEE I SAW NOW BETTER THAN NEVER SO WHAT AND WHO DO I REALLY THINK CARES NOT THAT IT MATTERS A JOT WHAT ANYONE OR EVERYONE ELSE THINKS OR EVEN WANTS WHY WORRY NOT MY PROBLEM THEIRS NO NOT EVEN NOBODIES EXCEPT POSSIBLY BUSY BODIES AND THEY CAN GO JUMP IN A LAKE OR ELSE FORGET IT HERE IS THE CORRECTION THE MISSING PAGE WHERE THINGS ARE AS THEY ARE AND WILL BE NOT BETTERED NO NOT BOTHERED YES BETTER IT COULD HAVE BEEN BUT WHATS THE POINT I ASK YOU ON AND ON AGAIN RAMBLING DOWNWARD DROPPING MY DS IN THE DARK GETTING PROGRESSIVELY SMALLER BIT BY BIT SLOWLY DISAPPEARING NEVER NOT GONE TOO QUICK OR COMPLETELY TIL NOTHING BUT A MUSH IM GUESSING CAUSE I REALLY DONT NO YET AND WONT TIL I GET WHERE IVE SET OUT TO BE BUT BY GOLLY ILL SWIFTA**E MY WAY THERE SOONER OR LATER ALL IN GOOD TIME WITH A
    [Show full text]
  • New Psychoactive Substances Among People Who Use Drugs Heavily in Europe
    2016 / 16 / 2 ORIGINAL ARTICLE New Psychoactive Substances among People Who Use Drugs Heavily in Europe An inventory of changing drug consumption patterns, shifting drug markets and lagging policy responses JANIKOVA, B. 1,2 , FIDESOVA, H. 1, VAVRINCIKOVA, L. 1, MIOVSKY, M. 1, GRUND, J-P. C. 1, 3, 4 1 Department of Addictology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic 2 National Monitoring Centre for Drugs and Addiction, Czech Republic 3 CVO – Addiction Research Centre, Utrecht, Netherlands 4 Freudenthal Institute for Science and Mathematics Education, Utrecht University, Utrecht, Netherlands Citation: Janíková, B., Fidesová, H., Miovský, M., Vavrinèíková, L., Grund, J-P. C. (2016). New Psychoactive Substances among People Who Use Drugs Heavily in Europe. An inventory of changing drug consumption patterns, shifting drug markets and lagging policy responses. Adiktologie, 16(2), 92–105. BACKGROUND: An increasing number of new psycho- review reports were collected from 22 countries, 21 from active substances (NPS) in seizures and their usage in vari- the EU plus Switzerland. RESULTS: 11 countries reported ous populations and, in some countries, heavily in the po- NPS use in PUDH, mainly on a local level; the injecting pulation of high-risk (including injecting) users is a general of NPS was reported from seven countries. Significant trend in Europe. It logically leads to the objective of finding groups of NPS among PUDH are cathinones and canna- out what the specific situation related to NPS in the con- binoids. Specific interventions responding to NPS use in text of the subpopulation of high-risk users is.
    [Show full text]